20 封面專題 • COVER STORY 澳大新語 • 2025 UMAGAZINE 32 Chair Professor Tang Zikang explains that IAPME’s commitment to cutting-edge scientific innovation and interdisciplinary collaboration has driven the development of advanced materials in emerging fields such as optoelectronic and electro-optical devices. The research team has expanded the functional capabilities of these materials, using multidimensional perovskite materials to develop bi-functional devices that can convert light to electricity and electricity to light. These devices achieve a light-to-electricity conversion efficiency of 26.7%, outperforming the typical 15% to 24% efficiency of commercial polycrystalline silicon solar cells. In addition, their electricity-to-light conversion as LEDs reaches an external quantum efficiency of approximately 32%, placing them among the world leaders in the field. IAPME also drives innovation in energy storage technologies. The research team led by Assistant Professor Li Qing, for example, specialises in improving the energy density and operational safety of next-generation batteries. Her team focuses on developing key components—such as positive and negative electrode materials, electrolytes, and separators—and innovating redox flow batteries. With a strong focus on practical applications, the team is working to design energy storage materials tailored for different scenarios, with the aim to extend battery lifespans, and enhance the efficient utilisation of renewable energy sources, including solar, tidal, wind, and hydrogen energy. A National Hub for Chinese Medicine Research and Development In alignment with SDG3 (Good Health and Wellbeing), UM’s Institute of Chinese Medical Sciences (ICMS) is actively leading efforts to modernise, standardise, and internationalise Chinese medicine. At the heart of this initiative is the State Key Laboratory of Mechanism and Quality of Chinese Medicine (SKL-MQCM), a platform dedicated to cutting-edge research and high-calibre talent development. This commitment is reflected in UM’s growing academic influence and success in talent development. In the 2023/2024 academic year, UM published more than 300 papers on Chinese medicine in SCI-indexed journals, bringing its total number of publications in the field to over 3,800. A major milestone was marked by publications in top-tier journals such as Science. Furthermore, UM was ranked 33rd globally in the 2024–2025 U.S. News & World Report Best Global Universities Rankings for pharmacology and toxicology, the highest ranking among higher education institutions in Hong Kong and Macao. The university has also risen to the top 0.1% globally in this field in the ESI database, underscoring its world-class status. In addition, established in 2002 with an enrolment of just over 30 students, ICMS has expanded its student body to over 500, and has produced more than 1,000 graduates to date. As Assistant Director Prof Lu Jinjian notes, this growth reflects UM’s dedication to nurturing talent for the Chinese medicine sector across research, academia, and industry. UM applies advanced scientific methods to analyse the active components of Chinese medicine and uses modern technology to uncover their mechanisms of action. Currently, researchers focus on addressing major health challenges, including autoimmune disorders, cancer, cardiovascular and cerebrovascular diseases, neurological disorders, and metabolic conditions. Notable achievements include the development of anti-tumour drugs targeting TNFR2, treatments for atopic dermatitis, and skin repair therapies derived 中藥來源化合物增強免疫治療抗癌效果 Compounds derived from Chinese medicine can enhance the anti‑cancer effects of immunotherapy 陸金健教授 Prof Lu Jinjian
RkJQdWJsaXNoZXIy NzM0NzM2